Abstract:The use of radioisotopes in nuclear medicine is essential for diagnosing and treating cancer. The optimization of their production is a key factor in maximizing the production yield and minimizing the associated costs. An efficient approach to this problem is the use of Monte Carlo simulations prior to experimentation. By predicting isotopes yields, one can study the isotope of interest expected activity for different energy ranges. One can also study the target contamination with other radioisotopes, especially undesired radioisotopes of the wanted chemical element which are difficult to separate from the irradiated target and might result in increasing the dose when delivering the radiopharmaceutical product to the patient. The aim of this work is to build and validate a Monte Carlo simulation platform using the GEANT4 toolkit to model the solid target system of the South Australian Health and Medical Research Institute (SAHMRI) GE Healthcare PETtrace cyclotron. It includes a GEANT4 Graphical User Interface (GUI) where the user can modify simulation parameters such as the energy, shape and current of the proton beam, the target geometry and material, the foil geometry and material and the time of irradiation. The paper describes the simulation and presents a comparison of simulated and experimental/theoretical yields for various nuclear reactions on an enriched nickel 64 target using the GEANT4 physics model QGSP_BIC_AllHP, a model recently developed to evaluate with high precision the interaction of protons with energies below 200MeV available in Geant4 version 10.1. The simulation yield of the (64)Ni(p,n)(64)Cu reaction was found to be 7.67±0.074 mCi·μA(-1) for a target energy range of 9-12MeV. Szelecsenyi et al. (1993) gives a theoretical yield of 6.71mCi·μA(-1) and an experimental yield of 6.38mCi·μA(-1). The (64)Ni(p,n)(64)Cu cross section obtained with the simulation was also verified against the yield predicted from the nuclear database TENDL and compared to experimental yield obtained from literature.

Investigation of Production Possibility of Medical Isotope 155Tb on Cyclotron C18/18

Study on Production Method of the {sup 178m2}hf Isomer for Induced Gamma Emission

155Tb production by cyclotrons: what level of 155Gd enrichment allows clinical applications?

Cross-section measurement of thulium radioisotopes with an 18 MeV medical PET cyclotron for an optimized 165Er production

Comparative study of 155Tb production via 155Dy precursor with p, d and α beams on natural targets for medical applications

Production possibility of 161Tb utilizing secondary neutrons generated by protons from a low-energy cyclotron onto an isotope production target

Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide

Investigation of production of medical 82Sr and 68Ge for 82Sr/82Rb and 68Ge/68Ga generators via proton accelerator

Investigation of 209Bi (α,2n)211At reaction route for the production of α-emitter 211At

Experimental Study of the Production of Medical Isotope Gallium-67 on the Beam of Yerevan Cyclotron

State of the Art in Cyclotrons for Radionuclide Production in Biomedicine

Production of 161Tb as a promising Auger electron emitter in Iran

Measurements of $^{152}$Gd(p,$γ$)$^{153}$Tb and $^{152}$Gd(p,n)$^{152}$Tb reaction cross sections for the astrophysical $γ$ process

Production of Medical Radioisotopes with High Specific Activity in Photonuclear Reactions with $γ$ Beams of High Intensity and Large Brilliance

The production and separation of 161Tb with high specific activity at the University of Utah

Development of cooling system of solid state target for irradiation under proton beam of C18 cyclotron

GEANT4 simulation of cyclotron radioisotope production in a solid target

Terbium-149 production: a focus on yield and quality improvement towards preclinical application

Production of Y-86 and other radiometals for research purposes using a solution target system

Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron